An analyst from Master Capital Trust said that Reliance is witnessing a strong bullish setup on the monthly chart as prices ...

Lupin shares continue to rise, trading at a new 52-week high of Rs 2,376 after a 15% return over two weeks. The Nifty Pharma ...

Lupin Ltd. acquires Huminsulin range from Eli Lilly, strengthening its position in the Indian diabetes market.

The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and ...

Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...

Lupin strengthens its diabetes portfolio with the acquisition of Huminsulin products from Eli Lilly, including Insulin Human ...

Shares of Lupin Ltd. 1.02 per cent to Rs 2190.50 in Thursday's trade as of 11:51AM (IST). The stock hit a high price of Rs ...

Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to ...

The multinational pharmaceutical company had previously used distribution and promotion agreements with Eli Lilly to market the Huminsulin line of products. Indian pharma giant Lupin's shares ...

Lupin has been marketing the 'Huminsulin' range of products through existing distribution and promotion agreements with Eli ...